73 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
RDY Dr. Reddy's Laboratories Ltd $35.7 $5.93B N/A
Article Searches
BioMarin's Vimizim Wins Nod in China for Rare Genetic Malady http://www.zacks.com/stock/news/425808/biomarins-vimizim-wins-nod-in-china-for-rare-genetic-malady?cid=CS-ZC-FT-425808 Jun 06, 2019 - BioMarin's (BMRN) Vimizim gains an NMPA nod in China for addressing patients suffering Morquio A syndrome, an ultra-rare genetic condition.
Zynerba Releases Data on Epilepsy Candidate, Stock Down http://www.zacks.com/stock/news/526215/zynerba-releases-data-on-epilepsy-candidate-stock-down?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-526215 Sep 19, 2019 - Zynerba (ZYNE) announces positive top-line results from the BELIEVE 1 study evaluating the efficacy and safety of Zygel in a heterogeneous group of rare and ultra-rare epilepsies.
The Zacks Analyst Blog Highlights: Dr. Reddy's, WNS and Azure Power http://www.zacks.com/stock/news/532018/the-zacks-analyst-blog-highlights-dr-reddys-wns-and-azure-power?cid=CS-ZC-FT-press_releases-532018 Sep 23, 2019 - The Zacks Analyst Blog Highlights: Dr. Reddy's, WNS and Azure Power
Mylan (MYL) to Pay $30M to Settle SEC Charges for EpiPen http://www.zacks.com/stock/news/543304/mylan-myl-to-pay-%2430m-to-settle-sec-charges-for-epipen?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-543304 Sep 30, 2019 - Mylan (MYL) sinks after the SEC charges it for misclassification of EpiPen.
New Strong Sell Stocks for November 11th http://www.zacks.com/stock/news/614102/new-strong-sell-stocks-for-november-11th?cid=CS-ZC-FT-tale_of_the_tape|new_zacks_#5_rank_stocks-614102 Nov 11, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for November 13th http://www.zacks.com/stock/news/617737/new-strong-sell-stocks-for-november-13th?cid=CS-ZC-FT-tale_of_the_tape|new_zacks_#5_rank_stocks-617737 Nov 13, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for November 15th http://www.zacks.com/stock/news/621253/new-strong-sell-stocks-for-november-15th?cid=CS-ZC-FT-tale_of_the_tape|new_zacks_#5_rank_stocks-621253 Nov 15, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Teva Reintroduces Generic Depo-Provera Injection in U.S. http://www.zacks.com/stock/news/277080/teva-reintroduces-generic-depo-provera-injection-in-us?cid=CS-ZC-FT-277080 Sep 27, 2017 - Teva (TEVA) announced the reintroduction of the generic equivalent to Depo-Prover Contraceptive Injection 150 mg/mL in the United States.
VIVUS (VVUS) Q3 Loss Narrows, Qsymia Falters, Shares Down http://www.zacks.com/stock/news/282370/vivus-vvus-q3-loss-narrows-qsymia-falters-shares-down?cid=CS-ZC-FT-282370 Nov 09, 2017 - VIVUS (VVUS) reported third-quarter results wherein it reported narrower-than- expected loss. However, Qsymia sales fell from the year-ago period.
Dr. Reddy's (RDY) Q3 Earnings Fall, Revenues Improve Y/Y http://www.zacks.com/stock/news/290129/dr-reddys-rdy-q3-earnings-fall-revenues-improve-y-y?cid=CS-ZC-FT-290129 Jan 25, 2018 - Dr. Reddy's (RDY) earnings per American Depositary Share were down 27.3% in third-quarter fiscal 2018 from the year-ago quarter while the top line beat the prior-year figure.

Pages: 12345678

<<<Page 6>